BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy
S Liang, D Zheng, X Liu, X Mei, C Zhou, C **ao… - Frontiers in …, 2023 - frontiersin.org
OX40 (CD134), a member of the TNF receptor superfamily, is a widely studied costimulatory
immune checkpoint. Several OX40 agonistic antibodies are in the clinical stage for cancer …
immune checkpoint. Several OX40 agonistic antibodies are in the clinical stage for cancer …